- GLP-1 RAs offer dual benefits for patients with mental illness, addressing metabolic disorders and potentially improving mental health outcomes.
- Weight-reducing effects and improved glycemic control were observed in patients with mental illness.
- GLP-1 RAs demonstrated beneficial effects on mental health in patients with and without mental disorders.
- Promising outcomes were seen for specific mental health conditions, including schizophrenia spectrum disorders, depression, bipolar disorder, and alcohol use disorder.
- Longer-term studies with larger sample sizes are needed to evaluate the long-term effects and potential use of GLP-1 RAs in treating mental illness.
Source: Psychoneuroendocrinology
